We then randomly selected ten clinical samples to detect VEGFR2 expression by immunohistochemistry and found that VEGFR2 expression was higher in CRC tissues than in healthy adjacent tissues (Figure 1d, Supplementary Figure 1f). The gene discussed is KDR; the disease is colorectal carcinoma.